Immune cell type, a macrophage, tied to lupus nephritis in children
Inflammatory macrophages, particularly M1-like macrophages, may be cause of more severe pediatric lupus nephritis, study says.| Lupus News Today
Inflammatory macrophages, particularly M1-like macrophages, may be cause of more severe pediatric lupus nephritis, study says.| Lupus News Today
NKT cell activators hold promise for potential systemic lupus erythematosus (SLE) treatment, preclinical data show.| Lupus News Today
RSLV-132 failed to lessen damage caused by skin lesions in SLE in a trial, but tended to ease symptoms in patients with more active disease.| Lupus News Today
The FDA has updated the prescribing label for Lupkynis to show that it continues to safely preserve kidney function for up to three years.| Lupus News Today
The FDA has approved Benlysta in an autoinjector that can be used at home to treat lupus nephritis, a kidney complication, in children.| Lupus News Today
Author archive page for Margarida Maia.| Lupus News Today
May marks Lupus Awareness Month, and advocates will be joining together to bring attention to the disease to help "Make Lupus Visible."| Lupus News Today
Ampel BioSolutions is launching LuGENE, a lupus blood test that uses AI to look at gene activity to predict flares and personalize treatments.| Lupus News Today
Lupus Therapeutics is teaming up with Artiva Biotherapeutics on a Phase 1 trial of AlloNK, a natural killer cell therapy for lupus nephritis.| Lupus News Today
Seattle Children's will start a clinical trial testing CAR T-cell therapy in children with lupus this summer after getting FDA clearance.| Lupus News Today
